Fact based stock research
Mainova (DB:MNV6)




Research has been discontinued. Contact us if you want research on this stock.



Mainova stock research in summary

far.com.au


Mainova shares have a SELL rating. They are riskily financed, are bad value, and show below average growth. We recommend selling Mainova shares.


Latest Obermatt Ranks


Country Germany
Industry Multi-Utilities
Index CDAX
Size class Medium

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Research History: Mainova

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
6
10
10
15
STOCK GROWTH RANKS
42
70
9
9
STOCK SAFETY RANKS
17
35
45
27
COMBINED STOCK RANKS
3
25
1
1

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Mainova in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Mainova; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
23
46
30
31
PROFIT GROWTH
94
94
94
12
STOCK RETURNS
39
63
40
41
CONSOLIDATED RANK: GROWTH
42
70
9
9

Financial reporting date of Growth Rank: 30-Jun-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Mainova.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
71
72
67
70
REFINANCING
11
18
18
18
LIQUIDITY
11
30
29
29
CONSOLIDATED RANK: SAFETY
17
35
45
27

Financial reporting date of Safety Rank: 30-Jun-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Mainova and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Mainova from March 22, 2018.